INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 35,166 Value ($000) $141 Avg Close — Range —
Q1 2025
Shares 180,015 Value ($000) $164 Avg Close — Range —
Q4 2024
Shares 616,909 Value ($000) $1,709 Avg Close — Range —
Q3 2024
Shares 49,560 Value ($000) $259 Avg Close — Range —
Q2 2024
Shares 25,895 Value ($000) $115 Avg Close — Range —
Q1 2024
Shares 92,718 Value ($000) $710 Avg Close — Range —
Q4 2023
Shares 159,463 Value ($000) $679 Avg Close — Range —
Q3 2023
Shares 134,010 Value ($000) $563 Avg Close — Range —
Q2 2023
Shares 145,600 Value ($000) $811 Avg Close — Range —
Q1 2023
Shares 793,823 Value ($000) $4,549 Avg Close — Range —
Q3 2022
Shares 110,648 Value ($000) $297 Avg Close — Range —
Q2 2022
Shares 120,827 Value ($000) $577 Avg Close — Range —
Q1 2022
Shares 98,297 Value ($000) $402 Avg Close — Range —
Q4 2021
Shares 106,978 Value ($000) $729 Avg Close — Range —
Q3 2021
Shares 94,466 Value ($000) $1,095 Avg Close — Range —
Q2 2021
Shares 171,066 Value ($000) $2,915 Avg Close — Range —
Q1 2021
Shares 240,401 Value ($000) $4,760 Avg Close — Range —
Q4 2020
Shares 252,542 Value ($000) $5,212 Avg Close — Range —
Q3 2020
Shares 241,078 Value ($000) $6,338 Avg Close — Range —